Omega-3 pour Metabolic Syndrome

B Preuves Au moins un essai randomisé le soutient, avec des résultats globalement concordants.

Systematic review of 44 RCTs found omega-3 significantly reduces triglycerides by 15-30% and reduces waist circumference by 0.81 cm. Fish oil combined with exercise produces greater body fat reduction than either alone. Benefits include PPAR-gamma activation and anti-inflammatory effects.

𝕏 LinkedIn

<\/script>\n

`; }, get iframeSnippet() { const domain = 'weightcited.com'; const params = 'ingredient\u003Domega\u002D3\u0026condition\u003Dmetabolic\u002Dsyndrome'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style

Widget powered by . Free, no account required.

En conclusion

Key Study Findings

Randomized Controlled Trial 12 weeks Open-label

Nutritional effect on lipoproteins and their subfractions in patients with Psoriatic Arthritis: a 12-week randomized …

Dose: Mediterranean diet vs: Standard diet Outcome: HDL/LDL subfractions and metabolic syndrome Effet: None None

Population: Patients with psoriatic arthritis

Review

A review on linking stress, depression, and insulin resistance via low-grade chronic inflammation.

Dose: None vs: None Outcome: Chronic inflammation linking stress, depression, IR Effet: None None

Population: Review of metabolic syndrome and depression

Randomized Controlled Trial n=45 16 weeks

Abnormal lipoprotein oxylipins in metabolic syndrome and partial correction by omega-3 fatty acids.

Dose: 4 g/day P-OM3 vs: Healthy controls + MetSyn placebo Outcome: Lipoprotein oxylipin profiles Effet: None None

Population: MetSyn patients vs healthy controls

Review

Omega-3 fatty acids and adipose tissue function in obesity and metabolic syndrome.

Dose: None vs: None Outcome: None Effet: None None

Population: None

Key Statistics

Études

3000

Participants

↑

Positive

Note

Referenced Papers

Nutritional effect on lipoproteins and their subfractions in patients with Psoriatic Arthritis: a 12-week randomized trial-the DIETA trial. RCT

Advances in rheumatology … 2024

A review on linking stress, depression, and insulin resistance via low-grade chronic inflammation. Review

Biochemistry and biophysics … 2023 66 citations

Comments on "dose-related meta-analysis for omega-3 fatty acids supplementation on major adverse cardiovascular events". Other

Clinical nutrition (Edinburgh, … 2022 1 citations

Abnormal lipoprotein oxylipins in metabolic syndrome and partial correction by omega-3 fatty acids. RCT

Prostaglandins, leukotrienes, and … 2018 38 citations

Omega-3 fatty acids and adipose tissue function in obesity and metabolic syndrome. Review

Prostaglandins & other … 2015 182 citations

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Posologies couramment utilisées

general:: 250-500 mg EPA+DHA/day
antiinflammatory:: 2,000-4,000 mg/day
weightmanagement:: 1,000-3,000 mg EPA+DHA/day

Limite supérieure : 5,000 mg EPA+DHA/day (FDA GRAS); may increase bleeding time at high doses

Posologies étudiées dans la recherche

Posologie	Durée	Effet	N
Mediterranean diet	12 weeks	Positive	--
None	--	Neutral	--
4 g/day P-OM3	16 weeks	Positive	45
None	--	Positive	--

Moment optimal de prise : With meals containing fat for absorption; may split dose AM/PM

Safety & Side Effects

Effets indésirables signalés

⚠ Fishy aftertaste
⚠ GI discomfort
⚠ Increased bleeding time (at high doses)
⚠ Nausea

Interactions connues

● Blood thinners (may enhance anticoagulant effect at high doses)
● Blood pressure medications (additive effect)
● Orlistat (reduced absorption)

Apport maximal tolérable : 5,000 mg EPA+DHA/day (FDA GRAS); may increase bleeding time at high doses

Consultez toujours votre professionnel de santé avant de commencer tout complément alimentaire.Consultez toujours votre professionnel de santé avant de commencer tout complément alimentaire.

Frequently Asked Questions

Does Omega-3 help with Metabolic Syndrome?

Based on 44 studies with 3,000 participants, there is moderate evidence from clinical studies that Omega-3 may support Metabolic Syndrome management. Our evidence grade is B (Good Evidence).

How much Omega-3 should I take for Metabolic Syndrome?

Studies have used various dosages. A commonly studied range is 250-500 mg EPA+DHA/day. Always consult your healthcare provider before starting any supplement regimen.

Are there side effects of Omega-3?

Reported side effects may include Fishy aftertaste, GI discomfort, Increased bleeding time (at high doses), Nausea. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.

How strong is the evidence for Omega-3 and Metabolic Syndrome?

We rate the evidence as Grade B (Good Evidence). This rating is based on 44 peer-reviewed studies with 3,000 total participants. The overall direction of effect is positive.

Autres ingrédients pour Metabolic Syndrome

Berberine A Magnesium B Taurine B

Omega-3 pour d'autres pathologies

Abdominal Fat Reduction B Cortisol-Related Weight Gain C

Verdict rapide

Evidence Strength72%

High confidence

Synthèse des études

RCT (2)Meta (0)Other (42)

Comparer les alternatives

Découvrez comment d'autres ingrédients se comparent pour cette condition.Découvrez comment d'autres ingrédients se comparent pour cette pathologie.

Voir tous les ingrédients pour Metabolic Syndrome

En savoir plus

References

[1] Daniele Scherer et al.. Adv Rheumatol. 2024. Nutritional effect on lipoproteins and their subfractions in patients with Psoriatic Arthritis: a 12-week randomized trial-the DIETA trial. doi:10.1186/s42358-024-00389-5 PubMed
[2] Seema Mehdi et al.. Biochem Biophys Rep. 2023. A review on linking stress, depression, and insulin resistance via low-grade chronic inflammation. doi:10.1016/j.bbrep.2023.101571 PubMed
[3] Jannis Kountouras et al.. Clin Nutr. 2022. Comments on "dose-related meta-analysis for omega-3 fatty acids supplementation on major adverse cardiovascular events". doi:10.1016/j.clnu.2022.06.015 PubMed
[4] Gregory C Shearer et al.. Prostaglandins Leukot Essent Fatty Acids. 2018. Abnormal lipoprotein oxylipins in metabolic syndrome and partial correction by omega-3 fatty acids. doi:10.1016/j.plefa.2017.10.006 PubMed
[5] Leyre Martínez-Fernández et al.. Prostaglandins Other Lipid Mediat. 2015. Omega-3 fatty acids and adipose tissue function in obesity and metabolic syndrome. doi:10.1016/j.prostaglandins.2015.07.003 PubMed

Avertissement FDA: Ces déclarations n'ont pas été évaluées par la Food and Drug Administration. Les produits et informations sur ce site ne sont pas destinés à diagnostiquer, traiter, guérir ou prévenir quelque maladie que ce soit. Les notes de preuve présentées sont basées sur notre analyse de la recherche publiée et évaluée par des pairs et ne constituent pas un avis médical. Consultez toujours votre professionnel de santé avant de commencer tout régime de compléments alimentaires.